# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
BTIG analyst Ryan Zimmerman maintains Stryker (NYSE:SYK) with a Buy and raises the price target from $360 to $374.
Stryker (NYSE:SYK), a global leader in medical technologies, announced today a definitive agreement to acquire Vertos Medical I...
Barclays analyst Matt Miksic maintains Stryker (NYSE:SYK) with a Overweight and raises the price target from $374 to $402.
Truist Securities analyst Richard Newitter maintains Stryker (NYSE:SYK) with a Hold and lowers the price target from $364 to...